Ontology highlight
ABSTRACT: Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer
PROVIDER: PRJNA348449 | ENA |
REPOSITORIES: ENA
ACCESS DATA